Positive Nellix Clinical Data From the EVAS FORWARD Global Registry Presented at 2015 VEITH Symposium
IRVINE, Calif., Nov. 19, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the presentation of updated clinical data from the Company's EVAS FORWARD - Global …